Moxifloxacin vs. Polytrim for Conjunctivitis
Information source: University of Rochester
Information obtained from ClinicalTrials.gov on December 08, 2011
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Conjunctivitis
Intervention: moxifloxacin (Drug); polytrim (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: University of Rochester Official(s) and/or principal investigator(s):
Francis Gigliotti, MD, Principal Investigator, Affiliation: University of Rochester
Overall contact:
Francis Gigliotti, MD, Phone: 585-275-5944, Email: Francis_gigliotti@urmc.rochester.edu
Summary
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and
Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications
are approved by the Food and Drug Administration, for treatment of conjunctivitis. This
study will investigate if both of the medications are equally good.
Clinical Details
Official title: A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.
Study design: Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Primary outcome: Clinical Cure
Secondary outcome: Microbiological cure
Eligibility
Minimum age: 1 Year.
Maximum age: 18 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- 1 - 18 years of age with presumed bacterial conjunctivitis.
Exclusion Criteria:
- Previous antibiotics or to receive systemic antibiotic.
Locations and Contacts
Francis Gigliotti, MD, Phone: 585-275-5944, Email: Francis_gigliotti@urmc.rochester.edu
University of Rochester, Rochester, New York 14642, United States; Recruiting
Additional Information
Starting date: March 2007
Last updated: August 11, 2011
|
